SCHEMBL14263141

SCHEMBL14263141

Cc1cc(F)cc(CNC(=O)NC2CCN(C)CC2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 6/20 0.53
HPGD P15428 4/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
RAB9A P51151 1/20 0.48
DRD4 P21917 1/20 0.45
MEN1 O00255 1/20 0.44
POLB P06746 1/20 0.44
KMT2A Q03164 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
RXFP1 Q9HBX9 1/20 0.44
HRH3 Q9Y5N1 1/20 0.43
ACKR3 P25106 1/20 0.43
EPHX1 P07099 2/20 0.42
SSTR4 P31391 3/20 0.41
SSTR1 P30872 1/20 0.41
KCNH2 Q12809 1/20 0.41
DRD2 P14416 1/20 0.40
ADRA1D P25100 1/20 0.40
ADRA1A P35348 1/20 0.40
ADRA1B P35368 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4983316 0.92 MCHR1 (0.51) MCHR1HPGDSMN1; SMN2RAB9ADRD4
SCHEMBL4981042 0.91 HPGD (0.53) MCHR1HPGDSMN1; SMN2RAB9ADRD4
SCHEMBL14263124 0.85 MCHR1 (0.48) MCHR1HPGDSMN1; SMN2RAB9ADRD4
SCHEMBL4981951 0.83 MCHR1 (0.56) MCHR1HPGDDRD4POLBKMT2A
SCHEMBL4982545 0.82 MCHR1 (0.66) MCHR1HPGDSMN1; SMN2RAB9ADRD4
SCHEMBL14263126 0.81 SSTR1 (0.57) MCHR1HPGDSMN1; SMN2RAB9ADRD4
SCHEMBL4978994 0.81 SMN1; SMN2 (0.72) MCHR1HPGDSMN1; SMN2RAB9ADRD4
SCHEMBL17896860 0.80 MAP4K4 (0.50) MEN1KMT2A
SCHEMBL4983041 0.80 EPHX1 (0.52) MCHR1HPGDSMN1; SMN2RAB9ADRD4
SCHEMBL14263140 0.80 MCHR1 (0.52) MCHR1HPGDSMN1; SMN2RAB9ADRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080064706-A1 Piperidine Derivatives as Histamine H3 Receptor Ligands ASTRAZENECA AB (SE) 2008-03-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080064706-A1 Piperidine Derivatives as Histamine H3 Receptor Ligands HRH3, HRH1, HRH4 MCHR1 132/4885HPGD 1184/4885SMN1; SMN2 4046/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.